¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Schizoaffective disorder, depressive type"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 4
¿µ¹® behavior disorder ÇÑ±Û ÇൿÀå¾Ö
¼³¸í   
  Á¤½ÅÀå¾Ö¸¦ °¡¸®Å°´Âµ¥ »ç¿ëµÇ´Â ¿ë¾î·Î¼­, Æ¯È÷ ÁöÀû, °¨Á¤Àû, ÇൿÀû Á¤½ÅÀå¾ÖÀ̸ç, ±âÁúÀû Àå¾Ö°¡ À־ »ý±â´Â °ÍÀº ¾Æ´Ï´Ù. Áö¼ÓÀûÀ¸·Î Å¸ÀÎÀÇ ±Ç¸®¸¦ Ä§¹üÇϰųª ³ªÀÌ¿¡ °É¸ÂÁö ¾Ê°Ô »çȸÀû ±Ô¹üÀ» ¾î±â´Â ÇൿÀÌ ³ªÅ¸³ª´Â Àå¾Ö·Î¼­, µµ½Ã¿¡¼­ ´õ ¸¹ÀÌ ³ªÅ¸³ª´Â °æÇâÀÌ ÀÖ´Ù. Á¤½ÅºÐ¼®ÇÐÀûÀΠ°ßÇØ¿¡ ÀÇÇϸ頵µ´öÀû ÃÊÀھư¡ ¼ºÀåÇÏÁö ¸øÇÏ¿© ³ªÅ¸³ª°Å³ª ºÎ¸ðÀÇ ¹«ÀǽÄÀûÀÌ°í ¹Ý»çȸÀû Ã浿ÀÌ ¾î¸°ÀÌ¿¡°Ô Àü´ÞµÇ¾î ÇൿȭÇϴ °ÍÀ̶ó°í ÇÑ´Ù. °¡Á¤È¯°æÀû ¿øÀÎÀ¸·Î´Â °á¼Õ°¡Á¤, ºÎ¸ðÀÇ °¥µî, ¾ËÄڿàÁßµ¶, ¾à¹°³²¿ë, ¹Ý»çȸÀû Çൿ µîÀ» µ¿¹ÝÇÑ ¾Æ¹öÁöÀÇ Á¤½Åº´¸®, Àϰü¼º ¾ø´Â ÈÆÀ°, ¾Æµ¿Çдë, ¾î¸Ó´ÏÀÇ ¿ì¿ïÁõ µîÀ» µé ¼ö ÀÖ´Ù. »ý¹°ÇÐÀû ¿äÀÎÀ¸·Î´Â À¯ÀüÀûÀ¸·Î Æ¯Á¤ À¯ÀüÁúº´À» ¾Î´Â È¯ÀÚÀÇ °æ¿ì¿¡ Æø·Â¼ºÀÌ µÎµå·¯Áö°Ô ³ªÅ¸³ª´Â °ÍÀ¸·Î º¸°íµÇ¾î ÀÖ°í, ³ú¼Õ»ó°ú ³úÆÄ ÀÌ»ó, °æ¹ÌÇÑ ½Å°æÇÐÀû ÀÌ»ó, È£¸£¸ó ºÒ±ÕÇü µîµµ ±× ¿øÀÎÀÌ µÇ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ÀÌ Àå¾Ö´Â ´ëºÎºÐ ÇнÀÀå¾Ö, ÁÖÀǷ °áÇÌ, °úÀ׿Àå¾Ö, ¿ì¿ïÀå¾Ö, ºÒ¾ÈÀå¾Ö, ¾à¹°³²¿ë µî°ú ÇÔ²² ³ªÅ¸³­´Ù. ¹Ì±¹ÀÇ Åë°è¿¡ ÀÇÇϸé 18¼¼ ÀÌÇÏÀÇ ³²¼º 6~16%, ¿©¼º 2~9%°¡ ÀÌ Àå¾Ö¸¦ °¡Áö°í Àִ °ÍÀ¸·Î º¸°íµÇ¾î ÀÖ´Ù. Çѱ¹ÀÇ °æ¿ì ÃʵîÇб³ 4~6Çг⠾ÀÌ Áß ³²¾Æ 5%, ¿©¾Æ 2.3%°¡ ÀÌ Àå¾Ö¸¦ °¡Áö°í Àִ °ÍÀ¸·Î º¸°íµÇ¾ú´Ù.
¿µ¹® histrionic personality disorder ÇÑ±Û È÷½ºÅ׸®ÀΰÝÀå¾Ö
¼³¸í   
  Áö³ªÄ¡°Ô ¿¬±ØÀûÀÌ°í ¹ÝÀÀÀûÀ̸ç ÇൿÀÇ Áö³ªÄ£ Ç¥Çö ¹× Æ¯À¯ÇÑ ´ëÀΰü°èÀÇ Àå¾Ö¸¦ ÁַΠÇϴ Á¤½Åº´. È÷½ºÅ׸®ÀΰÝÀå¾Ö´Â ¿ÜºÎ¿¡ ´ëÇÑ ¹ÝÀÀÀÌ Áö³ªÄ¡°Ô ºü¸£°í Àڱ⸦ °ú½ÃÇ졒ʫëÀΰü°è¿¡¼­ ÇÇ»óÀûÀÌ°í ºÒ¼º½ÇÇØ¼­ ´ëÀΰü°è¿¡ Àå¾Ö°¡ Àִ À̻󼺰ÝÀ¸·Î¼­ ¼º½É¸®°¡ ¹Ì¼÷ÇÑ °ÍÀ̠Ư¡ÀÌ´Ù. ¾ðÁ¦³ª ÀÚ½ÅÀ» ¸ÚÁö°Ô µå·¯³» º¸ÀÌ·Á ÇÏ°í ´Ù¸¥ »ç¶÷ÀÇ °ü½ÉÀ» ²ø±â À§ÇØ °úÀåµÈ Ç¥ÇöÀ» ÇÑ´Ù. ¾Æ´Â »ç¶÷À» ¸¸³ª¸é Áö³ªÄ¥ Á¤µµ·Î ¹Ý°¡¿öÇÏ°í ¸¶Ä¡ °øÁÖ³ª ¿ÕÀÚ°°Àº Ç༼¸¦ Çϴ ¼ö°¡ ÀÖ´Ù. ÀÛÀº Àڱؿ¡µµ ½±°Ô ÈïºÐÇϰí È­¸¦ Àß ³»³ª ÀÛÀº ±â»Ý¿¡ Áö³ªÄ¡°Ô ¹ÝÀÀÇϴ º¯´ö½º·¯¿î ¼º°ÝÀÇ ¼ÒÀ¯ÀÚÀÌ´Ù. ³í¸®ÀûÀΠ°Íº¸´Ù´Â °¨Á¤ÀûÀ¸·Î ÀÏÀ» Ã³¸®Ç졒ʫëÀΰü°è¿¡¼­ »ó´ë¹æÀÇ Àǻ縦 ÀÚ±â È¯»ó¿¡ µû¶ó ¸Ú´ë·Î Çؼ®ÇÑ´Ù. ºÒ¸¸½º·¯¿î ÀÏÀÌ ÀÖÀ¸¸é ÀÚ»ìÇÑ´Ù°í À§ÇùÇϰųª ÀÚ»ìÀÇ ¿¬±ØÀ» ²Ù¸ç¼­ »ó´ë¹æÀ» Á¶Á¤ÇÑ´Ù. Ç¥¸éÀûÀ¸·Î´Â °¨Á¤À̠dzºÎÇÏ°í ¸Å·ÂÀûÀÌ°í »ç±Í±â ½±Áö¸¸ ´ëÀΰü°è¿¡¼­ Áö¼Ó¼ºÀÌ ¾ø°í ½±°Ô »ç±Í¾ú´Ù°¡ ½±°Ô Çì¾îÁö°í ±³Á¦Çϴ »ç¶÷Àº ¸¹À¸³ª »ó´ë°¡ ÀÚÁÖ ¹Ù²ï´Ù. Çѹø »ç±Í°Ô µÇ¸é »ó´ë¹æÀÇ ÀÇ»ç´Â ¾Æ¶û°÷ÇÏÁö ¾Ê°í Àڱ⠿䱸¸¸ µé¾îÁֱ⸦ ¹Ù¶ó´Â À̱âÀûÀΠ»ç¶÷ÀÌ°í ±×°ÍÀÌ ÃæÁ·µÇÁö ¸øÇϸ頰ð ½Ç¸ÁÇÏ°í ±× »ç¶÷À» ¿ø¸ÁÇÑ´Ù. ¼ºÀû ÀûÀÀ·Âµµ Èñ¹ÚÇÏ¿© ¼ºÀûÀ¸·Î ¸Å·ÂÀÌ À־¸ÀÌ°í ¾Ö±³°¡ ÀÖ°í ¼ºÀû ºÐÀ§±â¸¦ ¹°¾À Ç³±âÁö¸¸ ºÒ°¨ÁõÀΠ°æ¿ì°¡ ¸¹´Ù. À̼º°ü°è¸¦ ³¶¸¸ÀûÀΠȯ»óÀ¸·Î ²ø°í °¡·Á°í ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • organic reaction type
    ±âÁú¹ÝÀÀÇü
  • ovulatory type
    ¹è¶õÇü
  • polymyarian type
    ´Ù±ÙÀ°Çü
  • precision type attachment
    Á¤¹ÐÇüºÎÂø
  • propagative type
    Áõ½ÄÇü
  • pyknic body type
    ´Ü½Åºñ¸¸½ÅüÇü
  • parthenogenetic type
    ´Ü¼º»ý½ÄÇü
  • split-electrode-type probe
    ºÐÇÒÀü±Ø´õµëÀÚ
  • sthenic type
    ±Ù·ÂÇü
  • storage-type
    ÃàÀûÇü
  • swaged cast type crown
    ¾ÐÀÎÇü±Ý°ü
  • sympathicotonic type
    ±³°¨½Å°æ±äÀåÇü
  • simple type schizophrenia
    ´Ü¼øÇüÁ¤½ÅºÐ¿­º´
  • viral hepatitis type A
    AÇü¹ÙÀÌ·¯½º°£¿°
  • viral hepatitis type B
    BÇü¹ÙÀÌ·¯½º°£¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • sweating disorder
    ¶¡Àå¾Ö
  • thought disorder
    »ý°¢Àå¾Ö, »ç°íÀå¾Ö
  • vascular disorder
    Ç÷°üÁúȯ, Ç÷°üÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Golgi type II neuron
    ªÀºÃà»è½Å°æ¼¼Æ÷
  • hebephrenic type schizophrenia
    ÆÄ°úÁ¤½ÅºÐ¿­º´
  • hemispheric type
    ¹Ý±¸Çü
  • hemochorial type
    À¶Ç÷¸ðÇü
  • holomyarian type
    ¿ÏÀü±ÙÀ°Çü
  • hypertrophic type
    ºñ´ëÇü
  • tuberculin-type hypersensitivity
    (¢¡delayed-type hypersensitivity) Áö¿¬°ú¹Î
  • introversion type
    ³»ÇâÇü
  • intuitive type
    Á÷°üÇü
  • lepromatous type
    ³ªº´Á¾Çü
  • leptosomatic type
    ¸¶¸¥Çü
  • mating type
    ±³¹èÇü
  • meromyarian type
    ºÎºÐ±ÙÀ°Çü
  • plaque-type mutation
    ÇöóÅ©Çüµ¹¿¬º¯ÀÌ
  • nomenclatural type
    ºÐ·ùÇÐÀû±âÁظí
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • human T cell leukemia virus type II
    Á¦2Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
  • hyperlipoproteinemia type III
    °íÁö´Ü¹éÇ÷Áõ III
  • hyperlipoproteinemia type IV
    °í´Ü¹éÇ÷Áõ IV Çü
  • hyperlipoprotenemia type II
    °íÁö´Ü¹éÇ÷Áõ II Çü
  • hyperproteinemia type III
    ´Ü¹é°úÀ×Ç÷(Áõ) III Çü
  • hypersensitivity reactions,delayed-type
    Áö¿¬Çü(òÀæÅû¡)
  • hypersensitivity reactions,type i(anaphylactic)
    IÇü
  • hypersensitivity reactions,type ii(antibody-dependent cell-mediate cyt
    IIÇü
  • hypersensitivity reactions,type iii(imune complex-mediated)
    IIIÇü
  • hypersensitivity reactions,type iv(cell-mediated)
    IVÇü
  • hypersensitivity, delayed-type
    Áö¿¬Çü °ú¹Î¹ÝÀÀ
  • hypersensitivity, immediate-type
    Áï½ÃÇü °ú¹Î¹ÝÀÀ
  • hypertrophic type
    ºñ´ëÇü
  • hypogammaglobulinemia, Swiss-type
    ½ºÀ§½ºÇü °¨¸¶±Û·ÎºÒ¸°ÀúÇ÷Áõ
  • personality, type A
    AÇü ÀΰÝ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • bell type
    Á¾¸ð¾ç, Á¾Çü.
  • blood group =b. type
    Ç÷¾×Çü(Ì´ËâÌ´).
  • blood group =b. type
    Ç÷¾×Çü(úìäûû¡).
  • blood type
    Ç÷¾×Çü(Ì´ËâÌ´).
  • blood type
    Ç÷¾×Çü(úìäûúþ)
  • body type
    üÇü
  • body type
    üÇü(ô÷úþ).
  • bubble type vaporizer
    ±âÆ÷Çü ±âÈ­±â
  • calcified hypertrophic type
    ¼®È¸È­ºñ´ëÇü
  • catatonic type
    ±äÀåÇü
  • cellular type dermatofibroma
    ¼¼Æ÷Çü ÇǺμ¶À¯Á¾
  • chief cell type i glomus cell
    °ú¸³¼¼Æ÷
  • cryptogenic type
    ÀáÀçÇü(ËöËøÌ´).
  • cryptogenic type
    ÀáÀçÇü(íÖî¤úþ).
  • crystal type
    °áÁ¤Çü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
IDS-SR Inventory for Depressive Symptomatology-Systems Review
MDE major depressive episode
MDI manic-depressive illness; metered dose inhaler; multiple daily injection; Multiscore Depression Inve...
MDP manic-depressive psychosis; maximum diastolic potential; maximum digital pulse; methylene diphosphat...
SADD Short-Alcohol Dependence Data [questionnaire]; standardized assessment of depressive disorders; Stud...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
ADD Attention Deficit Disorder
ADD-H Attention Deficit Disorder With Hyperactivity
ADHD Attention Deficit Hyperactivity Disorder
AD Autistic Disorder
APD Avoidant personality disorder
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mobile type diagnostic X ray apparatus
    À̵¿Çü Áø´Ü X¼± ÀåÄ¡
  • monocytic type
    ´ÜÇÙ±¸Çü
  • morphea-like type
    ¹Ý»ó °æÇÇÁõ °°Àº ÇüÅÂ
  • multifocal type
    ´Ù¹ß¼º
  • muscle tension type headache
    ±Ù ±äÀ强 µÎÅë
    ÈĵκÎ, Ç׺ÎÀÇ Áö¼ÓÀûÀÎ ¾Ð¹Ú°¨, ±³¾×°¨À» È£¼ÒÇÑ´Ù. ÀÌ ÁõÀÇ È¯ÀÚ´Â ½Å°æÁú·Î ±äÀåÇϱ⠽¬¿î »ç¶÷¿¡°Ô ¸¹°í °³Ã¼ÀÇ ±Ù±äÀ强¼ÒÀΰú ¾î¿ï¾îÁ® ±ÙÀÇ Áö¼ÓÀû ¼öÃà°ú ±ÙÀÇ ¼øÈ¯ ºÎÀü ¡æ ÅëÁõ ¹°Áú ¹ß»ý ¡æ ÅëÁõ ¡æ ±Ù ¼öÃàÀ̶ó´Â ¾Ç¼øÈ¯ÀÌ Çü¼ºµÇ´Â °ÍÀ¸·Î »ý°¢µÈ´Ù. Á÷¾÷¿¡ µû¸¥ ºÎÀÚ¿¬½º·¯¿î ÀÚ¼¼°¡ °ü·ÃÀÌ ÀÖ´Â °æ¿ìµµ ¸¹°í ½Åü, ½É¸®Àû ¾çÃø¸éÀ¸·ÎºÎÅÍÀÇ Á¢±ÙÀÌ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹´Ù.
  • muscular type of vein
    ±ÙÀ°Çü Á¤¸Æ
  • nonnecrotizing type
    ºñ±«»ç¼º ÇüÅÂ
  • oral-facial-digital syndrome, type I
    IÇü±¸-¾È¸é-ÁöÁõÈıº
    X-¿¬°ü¼º ¿ì¼º À¯Àüº´À¸·Î¼­ ³²ÀÚ¿¡°Ô´Â Ä¡¸íÀûÀ¸·Î ±¼ÁöÁõ, ´ÙÁöÁõ, ÇÕÁöÁõ µîÀÌ Æ¯Â¡À̸ç, µÎ°³, ¾È¸é, ¼³, ±¸°³ ¹× ÇÏ¾Ç ±âÇüÀ» ¼ö¹ÝÇϰųª Áö´É ÀúÇÏ, Å»¸ðÁõ, ¾È¸é Áö·ç¸¦ ¼ö¹ÝÇÑ´Ù.
  • pedunclated type
    À¯°æÇü
  • personality type
    Àμº
  • pontic of root extension type
    À¯±Ù °¡°øÃ¼
    ¼ÒÇüÀÇ Ä¡±ÙÀ» °¡Áö°í ¹ßÄ¡¿Í ¼Ó¿¡ ÀûÇյǴ °¡ °øÃ¼, Ä¡°æºÎ¿Í ÇüÅ ±×¸®°í Ä¡Àº¿¬°úÀÇ °ü°è°¡ ÀÚ¿¬¿¡ °¡±õ°í ½É¹ÌÀûÀÌ°í °¡Àå ¿ì¼öÇϸç, ÀåÂø ÈÄ Ä¡ÀºÀÌ ¾à°£ ÅðÃàÇÏ¿©µµ °¡°øÃ¼¿ÍÀÇ »çÀÌ¿¡ °ø±ØÀÌ »ý±âÁö ¾Ê°í »ç¿ë°¨µµ ¾çÈ£ÇÏ´Ù. ´ë°³ Áï½Ã °¡°ø ÀÇÄ¡·Î¼­ ¹ßÄ¡ Á÷ÈÄ¿¡ ÀåÂøµÈ´Ù.
  • precision type attachment
    Á¤¹ÐÇü ºÎÂø ÀåÄ¡
  • pseudohypertrophic type
    °¡¼º ºñ´ëÇü
  • recurring type
    Àç¹ß¼º
  • repository type of penicillin
    ÀúÀåÇü Æä´Ï½Ç¸°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
mental disorder A psychological syndrome or behavioural pattern that is associated with either subjective distress or objective impairment.
See: mental illness, behaviour disorder.
(05 Mar 2000)
personality disorder General term for a group of behavioural disorder's characterised by usually lifelong, ingrained, maladaptive patterns of deviant behaviour, lifestyle, and social adjustment that are different in quality from psychotic and neurotic symptoms; former designations for individuals with these personality disorder's were psychopath and sociopath.
See: antisocial personality disorder.
(05 Mar 2000)
pervasive developmental disorder A class of mental disorders of infancy, childhood, or adolescence characterised by distortions in the development of the multiple basic psychological functions involved in the development of social skills and language.
(05 Mar 2000)
pervasive development disorder <neurology, psychiatry> A large group of developmental disabilities which are neurological disorders, usually of unknown cause.
Characteristics include reduced abilities to understand language and communicate normally, reduced ability to socially interact with others in a normal manner, and limited variety in activities and interests. Individuals will also often respond in unusual ways to sensations, engage in repetitive activities, and resist changes to the environment or to daily routines.
Types of pervasive development disorder include autism, Retts Syndrome, Hellers Syndrome, and Aspergers Syndrome.
Acronym: PDD
(12 Jan 1998)
chromosome disorder An abnormal condition due to an abnormality of the chromosomes. For example, Down syndrome (the genetic abnormality featuring three chromosome 21s, instead of two, also refered to as trisomy 21) is a chromosome disorder.
(12 Dec 1998)
rumination disorder A mental disorder occurring in infancy characterised by repeated regurgitation of food; usually accompanied by weight loss or failure to gain weight.
(05 Mar 2000)
cocaine-related disorder <psychiatry> Disorders related or resulting from use of cocaine.
(12 Dec 1998)
cognition disorder <psychology> Disturbances in the mental process related to thinking, reasoning, and judgment.
(12 Dec 1998)
compulsive personality disorder <psychology> A personality disorder which is characterised by the avoidance of feelings, emotion and intimacy within a framework of strict adherence to rules and order.
(05 Jan 1998)
conduct disorder A repetitive and persistent pattern of behaviour in which the basic rights of others or major age-appropriate societal norms or rules are violated. These behaviours include aggressive conduct that causes or threatens physical harm to other people or animals, nonagressive conduct that causes property loss or damage, deceitfulness or theft, and serious violations of rules. The onset is before age 18.
(12 Dec 1998)
multiple personality disorder A dissociative disorder in which the individual adopts two or more distinct personalities. Each personality is a fully integrated and complex unit with memories, behaviour patterns and social friendships. Transition from one personality to another is sudden.
(12 Dec 1998)
conversion disorder A disorder whose predominant feature is a loss or alteration in physical functioning that suggests a physical disorder but that is actually a direct expression of a psychological conflict or need.
(12 Dec 1998)
polygenic disorder <genetics> Genetic disorders resulting from the combined action of alleles of more thanone gene (for example, heart disease, diabetes, and some cancers). Although such disorders are inherited, they depend on the simultaneous presence of several alleles, thus the hereditary patterns are usually more complex than those of single-gene disorders.
(14 Oct 1997)
posttraumatic stress disorder Development of characteristic symptoms following a psychologically traumatic event that is generally outside the range of usual human experience; symptoms include numbed responsiveness to environmental stimuli, a variety of autonomic and cognitive dysfunctions, and dysphoria.
(05 Mar 2000)
cyclothymic disorder An affective disorder characterised by periods of depression and hypomania. These may be separated by periods of normal mood.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á